STAAR Surgical Company Aktie
WKN: 870353 / ISIN: US8523123052
|
03.03.2026 22:36:17
|
STAAR Surgical Q4 Loss Narrows
(RTTNews) - STAAR Surgical Company (STAA) on Tuesday reported a fourth-quarter net loss of $18.3 million or $0.37 per share, down from a net loss of $34.2 million or $0.69 per share for the prior year quarter.
The year over year improvement in net loss was primarily attributable to higher gross profit and lower operating expenses before merger and restructuring expenses and foreign exchange gains, partially offset by merger and restructuring expenses.
Net sales were $57.8 million for the fourth quarter of 2025, up by 18.1% from $49.0 million in the prior year quarter. The year over year increase in net sales primarily reflected sales growth in China.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu STAAR Surgical Company
|
02.03.26 |
Ausblick: STAAR Surgical Company zieht Bilanz zum jüngsten Jahresviertel (finanzen.net) |
Analysen zu STAAR Surgical Company
Aktien in diesem Artikel
| STAAR Surgical Company | 16,50 | 1,57% |
|